Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA grants fast track designation to long-acting buprenorphine for opioid addiction

Nov. 5, 2015

FDA grants fast track designation to Insys' sublingual naloxone for opioid overdose

Oct. 30, 2015

U.S. and Italian team reports development of FAAH inhibitors

Oct. 29, 2015

NIAID awards SRI International contract to develop treatments for radiation exposure

Oct. 16, 2015

Addex Therapeutics reports efficacy of ADX-71441 in models of alcohol use disorder

Oct. 14, 2015

Pluristem and FDA agree development pathway for PLX-R18 in ARS

Sep. 21, 2015

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Sep. 7, 2015

Probuphine NDA resubmitted to FDA

Sep. 1, 2015

Regenerative peptide mitigates radiation-induced gastrointestinal damage

Aug. 24, 2015

FDA approves IND for Saniona's NS-2359 in the treatment of cocaine addiction

Aug. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...